Notes in Melanoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Skin \| Melanoma \| 1.1 \| Histology
Published	02/18/2024	Skin \| Melanoma \| 1.2 \| Melanocytic naevi (aka pigmented nevus, mole)
Published	02/18/2024	Skin \| Melanoma \| 1.3 \| DDx
Published	02/18/2024	Skin \| Melanoma \| 1.4 \| Epidemiology
Published	02/18/2024	Skin \| Melanoma \| 1.5.1 \| Aetiology / Risk factors
Published	02/18/2024	Skin \| Melanoma \| 1.6 \| Clinical presentation
Published	02/18/2024	Skin \| Melanoma \| 1.7.1 \| Pathology \| Growth phases of melanoma
Published	02/18/2024	Skin \| Melanoma \| 1.7.2 \| Pathology \| Microscopic features
Published	02/18/2024	Skin \| Melanoma \| 1.7.3 \| Pathology \| Standardised pathologic report
Published	02/18/2024	Skin \| Melanoma \| 1.8.1 \| Pathologic classification
Published	02/18/2024	Skin \| Melanoma \| 1.8.2 \| Superficial spreading melanoma
Published	02/18/2024	Skin \| Melanoma \| 1.8.3 \| Nodular melanoma
Published	02/18/2024	Skin \| Melanoma \| 1.8.4 \| Lentigo maligna
Published	02/18/2024	Skin \| Melanoma \| 1.8.5 \| Desmoplastic melanoma
Published	02/18/2024	Skin \| Melanoma \| 1.8.6 \| Nevoid melanoma
Published	02/18/2024	Skin \| Melanoma \| 2.1 \| Workup
Published	02/18/2024	Skin \| Melanoma \| 2.2 \| Staging (AJCC 8th edition 2017)
Published	02/18/2024	Skin \| Melanoma \| 2.3.1 \| Breslow thickness
Published	02/18/2024	Skin \| Melanoma \| 2.3.2 \| Clark level
Published	02/18/2024	Skin \| Melanoma \| 1.9 \| Biologic behaviour
Published	02/18/2024	Skin \| Melanoma \| 2.4 \| Prognostic factors
Published	02/18/2024	Skin \| Melanoma \| 2.5 \| Diagnostic challenges
Published	02/18/2024	Skin \| Melanoma \| 1.5.2 \| Pathogenesis
Published	02/18/2024	Skin \| Melanoma \| 3.2.1 \| Stage I-II \| Surgery \| Management of primary
Published	02/18/2024	Skin \| Melanoma \| 3.3.1 \| Stage III \| Surgery \| Management of primary
Published	02/18/2024	Skin \| Melanoma \| 3.2.2 \| Stage I-II (clinical) \| Management of regional LNs
Published	02/18/2024	Skin \| Melanoma \| 3.3.2 \| Stage III \| Management of regional LNs
Published	02/18/2024	Skin \| Melanoma \| 3.3.5 \| Stage III \| Adjuvant systemic therapy
Published	02/18/2024	Skin \| Melanoma \| 3.2.3 \| Stage I-II \| Adjuvant therapy
Published	02/18/2024	Skin \| Melanoma \| 3.4.2 \| Stage IV \| Oligometastatic disease \| Adjuvant therapy following complete resection
Published	02/18/2024	Skin \| Melanoma \| 3.5.1 \| Stage IV \| Systemic therapy
Published	02/18/2024	Skin \| Melanoma \| 3.4.1 \| Stage IV \| Oligometastatic disease \| Surgical metastatecomy
Published	02/18/2024	Skin \| Melanoma \| 3.3.6 \| Stage III \| Adjuvant radiotherapy for N+ disease
Published	02/18/2024	Skin \| Melanoma \| 3.3.7 \| Stage I-III \| Adjuvant radiotherapy \| Other indications
Published	02/18/2024	Skin \| Melanoma \| 3.3.8 \| Stage I-III \| Definitive radiotherapy
Published	02/18/2024	Skin \| Melanoma \| 3.6 \| Stage IV \| Brain metastases
Published	02/18/2024	Skin \| Melanoma \| 4.1 \| Special sites \| Mucosal melanoma
Published	02/18/2024	Skin \| Melanoma \| 3.3.4 \| Stage III \| Management of in-transit metastases
Published	02/18/2024	Skin \| Melanoma \| 4.2 \| Special sites \| Uveal and conjunctival melanoma
Published	02/18/2024	Skin \| Melanoma \| 3.1 \| Management overview
Published	02/18/2024	Skin \| Melanoma \| x.x \|  RT technique \| Adjuvant RT to primary site
Published	02/18/2024	Skin \| Melanoma \| Acral lentiginous melanoma
Published	02/18/2024	Skin \| Melanoma \| 3.3.3 \| Stage III \| Neo-adjuvant systemic therapy
Status	Last Update	Fields